FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder
24th May 2023 Uncategorised 0 FDA clears Braeburn’s long-acting Brixadi to treat opioid use disorder
zbecker
Wed, 05/24/2023 – 09:15
More: FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder
Source: fierce